Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Kimco Realty Corporation (HC) Common Stock (KIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Kimco Realty Corporation (HC) Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Kimco Realty Corporation (HC) Common Stock trades at $22.16 (market cap $14.82B). The key difference: Kimco Realty Corporation (HC) Common Stock is the larger of the two by market cap, and Kimco Realty Corporation (HC) Common Stock pays a 5.07% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Kimco Realty Corporation (HC) Common Stock for 1 Days on average.
| HALO | KIM | |
|---|---|---|
Market Cap | $12.58B | $14.82B |
Volume | 2,179,278 | 5,158,462 |
Sector | Health | Real Estate |
52-Week High | $115.22 | $26.38 |
52-Week Low | $61.63 | $19.78 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $22.98B |
Dividend Yield | — | 5.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Kimco Realty Corporation (HC) Common Stock
Kimco Realty is a real estate investment trust that owns and operates open-air, grocery-anchored shopping centers and mixed-use properties in the United States.
Read more on KIM →
